Can an indwelling pleural catheter (Pleur‑X) be placed at the bedside in the home for a hospice patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Home-Based PleurX Catheter Placement for Hospice Patients

Yes, indwelling pleural catheters (PleurX) can be safely placed at the bedside in the home setting for hospice patients, and this approach is particularly well-suited for this population given their limited life expectancy and need to minimize hospital visits. 1

Evidence Supporting Bedside Home Placement

Feasibility and Safety Profile

  • Bedside placement using local anesthesia is well-established, with 92% (47 of 51 patients) successfully receiving catheter insertion at the bedside in one series, allowing 71% of patients to be discharged home the following day. 2

  • A dedicated hospice program demonstrated excellent outcomes with 135 drainage procedures completed on 127 unique hospice patients over 27 months, showing procedure-related complications <4% and late complications <3%. 1

  • The average cost per procedure ($1030) compares favorably with outpatient provider fees, making this a cost-effective option for hospice agencies. 1

Clinical Rationale for Hospice Population

  • Indwelling pleural catheters are specifically recommended for patients with reduced life expectancy to minimize hospitalization length and avoid repeated hospital drainage or admission. 3

  • The British Thoracic Society guidelines explicitly state that indwelling pleural catheters are effective when length of hospitalization is to be kept to a minimum in patients with reduced life expectancy. 3

  • Mean survival in malignant pleural effusion patients is approximately 3 months (range 5 days to 37+ months), making minimally invasive home-based interventions ideal. 2

Quality of Life Benefits

Symptom Control and Patient Satisfaction

  • 96% of patients with tunneled pleural catheters derived symptomatic relief in a systematic review of 943 patients. 3

  • Patient satisfaction is high across multiple quality of life indices: In one study of 48 patients, 50% reported being moderately satisfied and 15% very satisfied with ease of mobility; 42% moderately satisfied and 6% very satisfied with symptomatic improvement. 4

  • Hospital readmissions are substantially reduced: 78% of patients did not require another hospitalization due to effusion-related symptoms after catheter placement. 5

Comparison to Alternative Approaches

  • Total hospital days are significantly fewer with indwelling pleural catheters (7 days) compared to talc slurry pleurodesis (18 days), with fewer patients requiring subsequent pleural procedures (14% vs 32%). 3

  • Immediate improvements in quality of life and dyspnea occur within 7 days of catheter placement. 3

Practical Implementation Considerations

Procedure Requirements

  • Ultrasound guidance should be used to guide pleural interventions, reducing complications and improving success rates. 3

  • The procedure requires trained staff to minimize duration and reduce risk of complications, but does not require an operating room or hospital setting. 3

  • Appropriate PPE should be worn as pleural procedures should be considered potential aerosol-generating procedures. 3

Catheter Management

  • Community nurse practitioners can effectively manage these catheters, preventing repeated hospital admissions in palliative patients. 4

  • The program was well-accepted by the interdisciplinary hospice team, patients, and families. 1

  • Catheters are discrete and easy to manage, with mean drainage time of 52 days. 5

Complication Profile

Common Complications

  • Pain is the predominant complication (35% of patients), but typically lasts <3 days and does not require catheter removal. 4

  • Infection rates are low: empyema 2.8%, cellulitis 3.4%, with only 8.5% of catheters requiring removal due to complications. 3

  • Short-term complications occur in 7% and long-term complications in 18% of patients, with most being mild and readily manageable. 5

Serious Complications

  • Tumor seeding along the catheter tract occurs in 0.8% of patients. 3

  • Catheter removal or replacement is needed in 15% due to infection, air leak, or blockage. 2

  • No patients died from catheter-related complications in multiple series. 2

Special Considerations for Hospice

Ideal Patient Selection

  • Patients with trapped lung or nonexpandable lung are particularly good candidates, as indwelling pleural catheters are preferred over chemical pleurodesis in this population. 3

  • Patients with recurrent malignant pleural effusions benefit most, avoiding repeated hospital drainage. 3

  • ECOG performance status 3-4 patients are appropriate candidates for this minimally invasive approach. 5

Spontaneous Pleurodesis

  • Spontaneous pleurodesis occurs in 16-46% of patients with indwelling catheters, potentially allowing catheter removal. 3, 2, 5

  • Daily drainage increases pleurodesis rates compared to symptom-based drainage, but patients should be counseled that daily drainage is not required for symptom control. 3

Key Pitfalls to Avoid

  • Do not place catheters in asymptomatic patients with pleural effusions, as therapeutic interventions should not be performed if patients are asymptomatic. 3

  • Ensure proper caregiver training is essential for successful outcomes and infection prevention. 6

  • Avoid this procedure in patients with pleural infection or multiple pleural loculations without first addressing these issues. 3

References

Research

A Tunneled Catheter Placement Program for Community Hospices.

Journal of pain and symptom management, 2024

Research

Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.